SCHEMBL6897797

SCHEMBL6897797

CC(C)[C@H](N)C(=O)c1ccc([C](c2ccccc2)c2ccccc2)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
PKM P14618 1/20 0.38
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
ALOX15 P16050 1/20 0.36
HDAC1 Q13547 2/20 0.36
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
CHRNA1 P02708 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4420284 0.83 GRN (0.40) NPC1RAB9APKMALDH1A1POLB
SCHEMBL8507553 0.82 CES2 (0.49) ALDH1A1CES2CES1MAPTALOX15
SCHEMBL14843883 0.80 KMO (0.40) NPC1RAB9AALDH1A1POLBCES2
SCHEMBL2800230 0.78 SLC7A5 (0.46) PKMKMO
SCHEMBL5067796 0.77 CA1 (0.38) NPC1RAB9APKMALDH1A1SMN1; SMN2
SCHEMBL7432353 0.77 PGR (0.48) NPC1RAB9AALDH1A1POLBCES2
SCHEMBL19318480 0.77 PGR (0.48) NPC1RAB9AALDH1A1POLBCES2
SCHEMBL8228098 0.77 PGR (0.48) NPC1RAB9AALDH1A1POLBCES2
SCHEMBL4403267 0.76 MDM2 (0.44) NPC1RAB9ASMN1; SMN2HDAC1MEN1
Hydrochloric Acid SCHEMBL10728681 0.75 MAPT (0.49) NPC1RAB9AALDH1A1POLBCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11629171-B2 Beta-hairpin peptidomimetics SPEXIS AG (CH) 2023-04-18 US disclosed
US-20210284693-A1 BETA-HAIRPIN PEPTIDOMIMETICS SPEXIS AG (CH) 2021-09-16 US disclosed
US-10829520-B2 Beta-hairpin peptidomimetics POLYPHOR AG (CH) 2020-11-10 US disclosed
CN-111770932-A Beta-hairpin peptidomimetics 波利弗尔股份公司 2020-10-13 CN disclosed
EP-3707153-A1 BETA-HAIRPIN PEPTIDOMIMETICS Polyphor Ag (CH) 2020-09-16 EP disclosed
US-20180072775-A1 Beta-Hairpin Peptidomimetics POLYPHOR AG (CH) 2018-03-15 US disclosed
EP-3274361-A1 BETA-HAIRPIN PEPTIDOMIMETICS Polyphor Ag (CH) 2018-01-31 EP disclosed
CN-107636007-A Beta hairpin peptide mimics 波利弗尔股份公司 2018-01-26 CN disclosed
WO-2016150576-A1 BETA-HAIRPIN PEPTIDOMIMETICS POLYPHOR AG (CH) 2016-09-29 WO disclosed
EP-1155435-A4 ELECTRO-PNEUMATIC DISTRIBUTOR FOR MULTIPLEXED $g(m)-TAS DEVICES UNIV NORTHEASTERN (US) 2004-08-11 EP disclosed
EP-1155435-A1 ELECTRO-PNEUMATIC DISTRIBUTOR FOR MULTIPLEXED $g(m)-TAS DEVICES NORTHEASTERN UNIVERSITY (US) 2001-11-21 EP disclosed
WO-2000041214-A1 ELECTRO-PNEUMATIC DISTRIBUTOR FOR MULTIPLEXED ν-TAS DEVICES NORTHEASTERN UNIVERSITY (US) 2000-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11629171-B2 Beta-hairpin peptidomimetics POLL, POLQ, HBZ NPC1 4602/4885RAB9A 3521/4885PKM 262/4885
US-20180072775-A1 Beta-Hairpin Peptidomimetics POLQ, POLL, POLM NPC1 4582/4885RAB9A 3511/4885PKM 328/4885
US-20210284693-A1 BETA-HAIRPIN PEPTIDOMIMETICS POLL, POLQ, POLM NPC1 4663/4885RAB9A 4045/4885PKM 196/4885
US-10829520-B2 Beta-hairpin peptidomimetics POLQ, POLL, POLM NPC1 4582/4885RAB9A 3511/4885PKM 328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.